Your session is about to expire
← Back to Search
ReActiv8 Therapy for Chronic Lower Back Pain (RESTORE Trial)
RESTORE Trial Summary
This trial will compare ReActiv8 Therapy to Optimal Medical Management (OMM) for treating people with Patellofemoral Pain Syndrome (PFPS).
RESTORE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRESTORE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RESTORE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My back pain moderately affects my daily activities.I have had surgery for scoliosis or currently have moderate to severe scoliosis.My leg pain is worse than my back pain, or I have nerve pain below the knee.I am 21 years old or older.I have issues with a back muscle called the lumbar multifidus.I have had chronic low back pain for more than 6 months.My back pain level is between 6 and 9 on a scale of 0 to 10.My back pain moderately affects my daily activities.I am willing and able to give my consent for treatment.Pain medications and physical therapy did not improve my condition.Pain medications and physical therapy did not improve my condition.My MRI shows a problem in my back that can be fixed with surgery.I am not eligible for spine surgery.I am following the best treatment plan for my condition as decided by my doctor.You should not use the ReActiv8 System.My back pain level is between 6 and 9 on a scale of 0 to 10.Exclusions related to mental and social factors.My BMI is over 35.I have no other health issues that would stop me from following the study's requirements.I have not had any surgeries that would exclude me from the trial.I have had chronic low back pain for more than 6 months.I am not eligible for spine surgery.
- Group 1: Treatment (ReActiv8)
- Group 2: Control (OMM)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are involved with this experiment?
"A total of 230 eligible participants are mandated for this investigation, spearheaded by Mainstay Medical. Barrow Brain & Spine in Phoenix, Arizona and Duke University in Durham, North carolina will serve as two pivotal sites during the conduct of this trial."
Is this experimental treatment being conducted in various Canadian locations?
"This clinical trial is utilizing the resources of Barrow Brain & Spine in Phoenix, Arizona; Duke University in Durham, North carolina; The Center for Clinical Research, LLC in Winston-Salem Oregon; and an additional 22 medical sites."
Are volunteers able to join this exploration currently?
"Affirmative, the information on clinicaltrials.gov indicates that this study is recruiting participants at present. This medical trial was initially posted July 14th 2021 and has most recently been refreshed November 9th 2022. 230 individuals are desired to partake in this experiment across 22 sites."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger